JP2012524884A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524884A5
JP2012524884A5 JP2012503715A JP2012503715A JP2012524884A5 JP 2012524884 A5 JP2012524884 A5 JP 2012524884A5 JP 2012503715 A JP2012503715 A JP 2012503715A JP 2012503715 A JP2012503715 A JP 2012503715A JP 2012524884 A5 JP2012524884 A5 JP 2012524884A5
Authority
JP
Japan
Prior art keywords
mmp
positive control
expression
matrix metalloproteinases
test compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503715A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524884A (ja
JP5330596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/029670 external-priority patent/WO2010115031A1/en
Publication of JP2012524884A publication Critical patent/JP2012524884A/ja
Publication of JP2012524884A5 publication Critical patent/JP2012524884A5/ja
Application granted granted Critical
Publication of JP5330596B2 publication Critical patent/JP5330596B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503715A 2009-04-01 2010-04-01 口腔用組成物の抗骨喪失および抗付着喪失作用 Expired - Fee Related JP5330596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16568509P 2009-04-01 2009-04-01
US61/165,685 2009-04-01
PCT/US2010/029670 WO2010115031A1 (en) 2009-04-01 2010-04-01 Anti bone-loss and anti attachment-loss effects of an oral composition

Publications (3)

Publication Number Publication Date
JP2012524884A JP2012524884A (ja) 2012-10-18
JP2012524884A5 true JP2012524884A5 (https=) 2013-07-25
JP5330596B2 JP5330596B2 (ja) 2013-10-30

Family

ID=42328354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503715A Expired - Fee Related JP5330596B2 (ja) 2009-04-01 2010-04-01 口腔用組成物の抗骨喪失および抗付着喪失作用

Country Status (19)

Country Link
US (1) US8637266B2 (https=)
EP (1) EP2414838B1 (https=)
JP (1) JP5330596B2 (https=)
CN (1) CN102365550B (https=)
AR (1) AR076177A1 (https=)
AU (1) AU2010232590B2 (https=)
BR (1) BRPI1013185A2 (https=)
CA (1) CA2757317C (https=)
CO (1) CO6420374A2 (https=)
DK (1) DK2414838T3 (https=)
ES (1) ES2432864T3 (https=)
MX (1) MX2011008438A (https=)
MY (1) MY158406A (https=)
PL (1) PL2414838T3 (https=)
RU (1) RU2524629C2 (https=)
SG (1) SG173487A1 (https=)
TW (1) TWI405565B (https=)
WO (1) WO2010115031A1 (https=)
ZA (1) ZA201106054B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101745067B1 (ko) * 2014-12-31 2017-06-12 서울대학교산학협력단 치주질환 예측 시스템 및 이를 이용한 치주질환 예측 방법
KR102098624B1 (ko) * 2019-09-20 2020-04-08 서울대학교산학협력단 타액 mmp-9 및 il-8를 이용한 치주염 예측 시스템 및 이를 이용한 치주염 예측 방법

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5032386A (en) 1988-12-29 1991-07-16 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5840302A (en) 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
ES2162304T3 (es) 1996-06-12 2001-12-16 Cognis Deutschland Gmbh Preparaciones cosmeticas y/o farmaceuticas.
US5998487A (en) * 1998-04-08 1999-12-07 Colgate-Palmolive Company Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6165447A (en) * 1999-06-15 2000-12-26 Colgate-Palmolive Company Synergistic antibacterial combination
EP2295968B1 (en) 1999-12-03 2012-09-19 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
BR0313724A (pt) * 2002-08-13 2005-06-28 Warner Lambert Co Derivados de azaisoquinolina como inibidores de metaloproteinase de matriz
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200509958A (en) 2003-02-14 2005-03-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
US7202234B2 (en) 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
EP1701978B1 (en) 2003-12-03 2009-02-11 Whitehead Institute For Biomedical Research Use of soluble T-Cadherin for the treatment of metabolic disorders
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
JP4662043B2 (ja) * 2004-09-09 2011-03-30 国立大学法人東京農工大学 歯周病発症の評価システム
CN101111288A (zh) * 2004-12-02 2008-01-23 高露洁-棕榄公司 含酚类化合物和抗氧化剂维生素和维生素衍生物的口腔护理组合物
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP5024506B2 (ja) * 2005-03-25 2012-09-12 ライオン株式会社 歯周組織破壊の抑制・改善剤及び口腔用組成物
AU2007204730B2 (en) 2006-01-10 2011-11-17 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
EP2207546A1 (en) 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails
TWI481870B (zh) * 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記

Similar Documents

Publication Publication Date Title
US11864740B2 (en) Sample collection and preservation devices, systems and methods
Pinto et al. Clinical and microbiological effect of calcium hydroxide protection in indirect pulp capping in primary teeth.
Martinez et al. Idiopathic pulmonary fibrosis
Mawardi et al. Current understanding of the relationship between periodontal and systemic diseases
Pozhitkov et al. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism
Huang et al. Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison of HK‐2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells
Heng et al. Oral bacteriome and mycobiome across stages of oral carcinogenesis
JP2012522994A5 (https=)
JP2013518244A5 (https=)
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
BR112015029318A2 (pt) marcadores específicos de caminhos para diagnóstico da síndrome do intestino irritável
De Melo et al. COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system
Auld et al. Pathogenesis of post-tuberculosis lung disease: defining knowledge gaps and research priorities at the second international post-tuberculosis symposium
JP2016520611A5 (https=)
Xia et al. Methods for the detection and characterization of Streptococcus suis: from conventional bacterial culture methods to immunosensors
JP2015521728A5 (https=)
Han et al. Effect of miR-29a inhibition on ventricular hypertrophy induced by pressure overload
JP2012524884A5 (https=)
CN106574923B (zh) 食物过敏的检验方法及检验用试剂盒
WO2013049398A2 (en) Protein-protein interaction as biomarkers
Schara et al. Prevalence of periodontal pathogens and metabolic control of type 1 diabetes patients.
Harikrishna et al. Infectious purpura fulminans
Grek et al. S-glutathionylation of buccal cell proteins as biomarkers of exposure to hydrogen peroxide
RU2011144028A (ru) Эффекты пероральной композиции против потери костной массы и потери прикрепления
Zhang et al. Saliva diagnostics for oral diseases